| Primary |
| Drug Use For Unknown Indication |
36.0% |
| Asthma |
29.9% |
| Product Used For Unknown Indication |
28.2% |
| Hypersensitivity |
1.6% |
| Rhinitis Allergic |
0.8% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Hypertension |
0.5% |
| Depression |
0.3% |
| Chronic Obstructive Pulmonary Disease |
0.3% |
| Rhinitis |
0.2% |
| Diabetes Mellitus |
0.2% |
| Dyspnoea |
0.2% |
| Urticaria |
0.2% |
| Bronchitis |
0.2% |
| Pain |
0.2% |
| Anxiety |
0.2% |
| Hypothyroidism |
0.1% |
| Sinusitis |
0.1% |
| Premedication |
0.1% |
| Anaphylactic Reaction |
0.1% |
|
| Asthma |
15.3% |
| Wheezing |
12.2% |
| Anaphylactic Reaction |
10.8% |
| Urticaria |
7.2% |
| Death |
6.8% |
| Dyspnoea |
5.8% |
| Pneumonia |
4.9% |
| Pruritus |
3.5% |
| Weight Increased |
3.5% |
| Throat Tightness |
3.4% |
| Vomiting |
3.1% |
| Hypersensitivity |
3.1% |
| Rash |
2.9% |
| Malaise |
2.8% |
| Myocardial Infarction |
2.6% |
| Nasopharyngitis |
2.5% |
| Sinusitis |
2.5% |
| Pyrexia |
2.4% |
| Cough |
2.4% |
| Weight Decreased |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
44.6% |
| Asthma |
29.0% |
| Drug Use For Unknown Indication |
21.2% |
| Hypersensitivity |
1.5% |
| Rhinitis Allergic |
0.7% |
| Dyspnoea |
0.4% |
| Bronchitis |
0.3% |
| Chronic Obstructive Pulmonary Disease |
0.3% |
| Off Label Use |
0.3% |
| Rhinitis Seasonal |
0.2% |
| Urticaria |
0.2% |
| Osteoporosis |
0.2% |
| Rhinitis |
0.2% |
| Pain |
0.2% |
| Gastrooesophageal Reflux Disease |
0.2% |
| Hypertension |
0.1% |
| Blood Immunoglobulin E Increased |
0.1% |
| Seasonal Allergy |
0.1% |
| Depression |
0.1% |
| Diabetes Mellitus |
0.1% |
|
| Wheezing |
23.6% |
| Asthma |
13.4% |
| Nasopharyngitis |
5.6% |
| Weight Increased |
5.2% |
| Sinusitis |
4.2% |
| Urticaria |
4.2% |
| Pneumonia |
4.1% |
| Sputum Discoloured |
4.0% |
| Cough |
3.7% |
| Dyspnoea |
3.5% |
| Upper Respiratory Tract Infection |
3.5% |
| Weight Decreased |
3.4% |
| Malaise |
3.2% |
| Fatigue |
3.0% |
| Headache |
2.9% |
| Treatment Noncompliance |
2.7% |
| Vomiting |
2.7% |
| Pyrexia |
2.7% |
| Productive Cough |
2.4% |
| Throat Tightness |
2.2% |
|
| Concomitant |
| Asthma |
43.6% |
| Product Used For Unknown Indication |
16.8% |
| Hypersensitivity |
5.4% |
| Chronic Obstructive Pulmonary Disease |
3.1% |
| Drug Use For Unknown Indication |
3.1% |
| Hypertension |
2.9% |
| Osteoporosis |
2.6% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Pain |
2.2% |
| Diabetes Mellitus |
2.0% |
| Multiple Allergies |
1.9% |
| Pulmonary Arterial Hypertension |
1.9% |
| Anxiety |
1.8% |
| Cystic Fibrosis Lung |
1.8% |
| Depression |
1.8% |
| Migraine |
1.6% |
| Blood Cholesterol Increased |
1.3% |
| Cerebrovascular Accident Prophylaxis |
1.3% |
| Arthritis |
1.2% |
| Atrial Fibrillation |
1.2% |
|
| Wheezing |
9.5% |
| Asthma |
8.3% |
| Bronchitis |
7.1% |
| Incorrect Route Of Drug Administration |
6.0% |
| Weight Increased |
6.0% |
| Allergic Granulomatous Angiitis |
4.8% |
| Death |
4.8% |
| Haemoptysis |
4.8% |
| Oedema Peripheral |
4.8% |
| Pharmaceutical Product Complaint |
4.8% |
| Suicidal Behaviour |
4.8% |
| Urinary Tract Infection |
4.8% |
| Vomiting |
4.8% |
| Drug Exposure During Pregnancy |
3.6% |
| Nervous System Disorder |
3.6% |
| Off Label Use |
3.6% |
| Pain |
3.6% |
| Paraesthesia |
3.6% |
| Rash Pruritic |
3.6% |
| Renal Failure Acute |
3.6% |
|
| Interacting |
| Asthma |
77.8% |
| Bronchitis |
11.1% |
| Off Label Use |
11.1% |
|
| Urticaria |
71.4% |
| Rhinitis |
14.3% |
| Toxicity To Various Agents |
14.3% |
|
